Updated:
Finorpa
Finorpa Gestion deploys a hybrid of public and private capital in Hauts-de-France via three funds spanning deeptech venture to SME co-investment.
Finorpa
Finorpa Gestion est une société de gestion agréée par l’AMF qui intervient dans le financement en fonds propre et quasi fonds propre de TPE/PME régionales.
General information
Firm type
Private Equity
Year founded
—
AUM
Undisclosed
Location
Region
Europe
Country
France
City
Lille
Corporate office
4 square Dutilleul, 59800 Lille, France
Additional offices
Maison du Développement, 16 place Victor Hugo, 62500 Saint-Omer, France · 6 boulevard de Belfort, 80000 Amiens, France
Sector focus
Frequently asked questions
How is Finorpa structured and what vehicles does it manage?
Finorpa operates through three distinct funds. Finorpa SCR invests equity and quasi-equity in regional SMEs and holds a mixed public-private shareholder base. Captech Santé is a venture capital fund focused on deeptech startups in health, investing from seed to Series A across biotech, medtech, e-health and nutrition. Hauts-de-France Avenir TPE PME is a regional co-investment fund that partners with private investors on development and buyout-stage TPE/PME deals, providing up to €500,000 per transaction.
What is Finorpa's geographic investment focus?
The firm is deeply anchored in the Hauts-de-France region of northern France. Its offices in Lille, Saint-Omer and Amiens reflect a deliberately local deployment strategy, and the investment mandate of each fund is tied to the regional economy. Finorpa does not market a national or cross-border investment scope.
Does Finorpa participate in fund commitments or only direct deals?
Finorpa invests directly in companies across its three vehicle strategies. Hauts-de-France Avenir TPE PME operates as a co-investment fund alongside private capital partners such as other investment funds, family offices and business angels. There is no indication of a fund-of-funds program in the disclosed strategy.
What investment stages and ticket sizes does Finorpa target?
Through Captech Santé, the firm targets early-stage health-tech companies from seed to Series A. Hauts-de-France Avenir TPE PME targets development and buyout-stage TPE/PME with ticket sizes up to €500,000. Finorpa SCR pursues a long-term, flexible capital approach for regional SMEs across growth phases.
Who runs investment decisions at Finorpa?
Finorpa does not publicly list named investment principals or an executive team on its website. The regulated management company, Finorpa Gestion, holds AMF authorization (GP1600020), indicating that investment decisions are executed through a formally governed entity. Additional governance or committee details are not publicly disclosed.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: